KEQU - NASDAQ

Kewaunee Scientific Corporation

KEQU·NASDAQ

$38.00

-6.3%

Consumer CyclicalFurnishings, Fixtures & Appliances

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. It operates through two segments, Domestic and International. The company's products include steel, wood, laminate furniture, fume hoods, biological safety cabinets, laminar flow and ductless hoods, adaptable modular and column systems, moveable workstations and carts, epoxy resin worksurfaces, sinks, and accessories and related design services. Its laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and health care markets; technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture; and laminate caseworks that are used in educational, healthcare, and industrial applications. The company sells its products primarily through dealers, its subidiaries, and a national distributor. Kewaunee Scientific Corporation was founded in 1906 and is headquartered in Statesville, North Carolina.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$108.92M

EPS3.9800

P/E Ratio9.55

Earnings Date07/01/2026

194.65M

Assets

44%

3Y+64.0%

5Y+132.0%

10Y+169.0%

128.41M

Total Liabilities

63%

3Y+55.0%

5Y+184.0%

10Y+279.0%

66.25M

Total Equity

18%

3Y+83.0%

5Y+71.0%

10Y+72.0%

Kewaunee Scientific Corporation Funding & Solvency Profile

KEQU · NASDAQ

Current Assets

Cash & Cash Equivalents14.94M

Net Receivables62.38M

Inventory32.85M

Other Current Assets8.19M

Total Current Assets118 M

Non-Current Assets

Property, Plant & Equipment36.14M

Goodwill & Intangible Assets30.32M

Long-Term Investments1.86M

Other Non-Current Assets3.98M

Total Non-Current Assets42 M

Total Assets

194.65M

Financial Health Analysis

Current Ratio

2.20x

Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.

Debt-to-Equity Ratio

1.94x

Elevated leverage. Debt exceeds equity, which amplifies both gains and risks. Monitor debt servicing ability.

Working Capital

65 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

61% Current

Asset-light business model with high liquidity. Majority of assets are easily convertible to cash.

Financial Health Insight

Mixed signals: Strong short-term liquidity provides comfort, but high overall leverage requires careful monitoring of debt servicing capabilities and refinancing risk.

Kewaunee Scientific Corporation Balance Sheet

KEQU • NASDAQ

Kewaunee Scientific Corporation Balance Sheet	Apr 2025	Apr 2024	Apr 2023	Apr 2022	Apr 2021	Apr 2020	Apr 2019	Apr 2018	Apr 2017	Apr 2016	Apr 2015	Apr 2014	Apr 2013	Apr 2012	Apr 2011	Apr 2010	Apr 2009	Apr 2008	Apr 2007	Apr 2006
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	14.9M	23.3M	8.1M	4.4M	5.2M	4.4M	10.6M	9.7M	12.5M	5.2M	3M	6.2M	5.8M	6.2M	2.4M	1.7M	3.6M	3.8M	2.2M	929K
Cash & Short-Term Investments	14.9M	23.3M	8.1M	4.4M	5.2M	4.4M	10.6M	9.7M	12.5M	5.2M	3M	6.2M	5.8M	6.2M	2.4M	1.7M	3.6M	3.8M	2.2M	929K
Net Receivables	62.4M	45.1M	46.1M	54.7M	32.9M	28.1M	33.3M	32.7M	29.9M	27.8M	29.1M	23.5M	25.9M	23.2M	27.3M	26.2M	24.5M	20.1M	19.1M	23.2M
Accounts Receivables	62.4M	45.1M	46.1M	54.7M	32.9M	28.1M	33.3M	32.7M	29.9M	27.8M	29.1M	23.5M	25.9M	23.2M	27.3M	26.2M	24.5M	20.1M	19.1M	23.2M
Inventory	32.8M	20.7M	21.9M	23.8M	16.5M	15.3M	17.2M	17.7M	14.9M	15.6M	12.7M	11.9M	13.2M	11.8M	10.5M	8.4M	7.8M	7M	5.9M	5.9M
Prepaids	0.0	3M	0.0	6.2M	4.4M	2.9M	3.7M	2.2M	1M	707K	735K	680K	987K	989K	1.2M	1.4M	856K	1.4M	684K	633K
Other Current Assets	8.2M	4.8M	11.9M	2.5M	1.5M	3.6M	509K	1.2M	1.4M	1.6M	3.1M	1M	1.3M	1.4M	984K	934K	765K	887K	669K	777K
Total Current Assets	118.4M	96.8M	87.9M	91.6M	60.5M	54.2M	65.4M	63.5M	59.8M	51M	48.8M	43.4M	47.2M	43.6M	42.4M	38.6M	37.5M	33.2M	28.5M	31.4M
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	36.1M	25.1M	25.6M	22.7M	25.3M	25.6M	16.5M	14.7M	14M	14.1M	14.5M	14.6M	15.1M	15.3M	16.6M	13.8M	11.4M	11.8M	11.3M	11.2M
Goodwill	12.5M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Intangible Assets	17.8M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Goodwill & Intangible Assets	30.3M	0.0	-1.1M	-1.2M	0.0	-2.5M	-3.1M	-4.1M	0.0	0.0	0.0	0.0	-6.3M	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Long-Term Investments	1.9M	0.0	1.1M	1.2M	1.3M	2.5M	3.1M	4.1M	0.0	0.0	0.0	0.0	4.1M	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax Assets	4M	7.4M	943K	428K	0.0	336K	1.8M	2M	3.2M	3.4M	2.5M	1.4M	2.2M	1.7M	399K	663K	351K	407K	129K	378K
Other Non-Current Assets	4M	5.4M	4.5M	4.1M	2.4M	3.8M	3.6M	4.2M	3.4M	3.9M	3.7M	3.4M	6.4M	3.5M	3.7M	3.6M	3.3M	5.2M	5.3M	7.5M
Total Non-Current Assets	76.3M	37.9M	31M	27.2M	28.9M	29.7M	21.9M	20.9M	20.6M	21.4M	20.7M	19.4M	21.5M	20.5M	20.7M	18M	15M	17.4M	16.7M	19.1M
Total Assets	194.7M	134.8M	118.9M	118.8M	89.4M	83.9M	87.2M	84.4M	80.4M	72.4M	69.5M	62.7M	68.7M	64.1M	63.1M	56.6M	52.5M	50.6M	45.2M	50.5M
LIABILITIES
CURRENT LIABILITIES
Total Payables	27M	23.3M	23.6M	27.3M	16.8M	13.1M	15.2M	14.8M	12M	11.7M	11.2M	8.5M	10.4M	8.8M	9.8M	9.5M	8.8M	8.9M	8.4M	9.1M
Accounts Payable	27M	23.3M	23.6M	27.3M	16.8M	13.1M	15.2M	14.8M	12M	11.7M	11.2M	8.5M	10.4M	8.8M	9.8M	9.5M	8.8M	8.9M	8.4M	9.1M
Accrued Expenses	3.3M	1.1M	1.8M	4.5M	4.7M	4.2M	1.5M	3.8M	2.8M	2.3M	1.9M	2M	2.1M	1.3M	0.0	1.4M	1.7M	2M	1.4M	991K
Short Term Debt	3.9M	3.1M	3.6M	2.2M	6.8M	4.7M	10.7M	5.1M	4.5M	4.2M	5.4M	3.6M	7.2M	7.1M	6.9M	5M	5.9M	4.9M	3.8M	8.5M
Capital Lease Obligations (Current)	3.4M	2.2M	2.1M	1.4M	1.4M	1.3M	17K	0.0	0.0	0.0	0.0	0.0	0.0	36K	83K	82K	220K	323K	0.0	0.0
Tax Payables	0.0	0.0	0.0	0.0	0.0	0.0	0.0	546K	0.0	0.0	0.0	0.0	5.2M	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Deferred Revenue	6.1M	4.4M	4.1M	3.5M	3.1M	2.5M	1.6M	1.9M	5.8M	785K	216K	137K	488K	1.4M	1.1M	586K	1.3M	667K	1.7M	535K
Other Current Liabilities	10M	6.8M	4.9M	3.3M	1.4M	1.3M	3.7M	2.1M	1.9M	1.9M	2.3M	1.9M	1.9M	2.4M	2.4M	4M	1.4M	886K	2.5M	1.3M
Total Current Liabilities	53.7M	40.8M	40.1M	42.3M	34.2M	27.1M	32.7M	27.6M	26.9M	21M	21.1M	16.2M	22.1M	20.2M	20.3M	18.5M	18.7M	17.3M	16.2M	20.4M
NON-CURRENT LIABILITIES
Long Term Debt	33.9M	0.0	28.1M	28.8M	0.0	0.0	97K	1.3M	2.4M	3.3M	3.8M	4.2M	3.3M	3.5M	3.7M	0.0	0.0	0.0	0.0	0.0
Deferred Revenue (Non-Current)	0.0	0.0	-943K	0.0	0.0	-401K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Deferred Tax Liabilities (Non-Current)	1.1M	1.2M	943K	428K	307K	401K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	921K	0.0	247K
Other Non-Current Liabilities	30.7M	30.9M	-24.1M	-24.1M	5.5M	9.9M	6.6M	8M	8.3M	9.6M	9.5M	8.1M	9.7M	8.8M	6.1M	6.3M	5.4M	3.6M	3.4M	2.9M
Total Non-Current Liabilities	74.7M	37.8M	40.4M	40.3M	13.7M	18.2M	6.8M	9.3M	9.3M	12.9M	13.2M	12.3M	12.9M	12.2M	9.8M	6.5M	5.6M	4.6M	3.8M	3.7M
Capital Lease Obligations	12.3M	7.9M	37.5M	36.6M	9.3M	9.1M	149K	132K	0.0	0.0	0.0	0.0	0.0	36K	119K	82K	421K	153K	476K	583K
Total Liabilities	128.4M	78.6M	80.4M	82.6M	47.9M	45.2M	39.5M	36.8M	36.3M	33.9M	34.3M	28.5M	35M	32.5M	30M	24.9M	24.3M	21.9M	20M	24.1M
SHAREHOLDERS' EQUITY
Treasury Stock	-3.6M	-2.1M	-53K	-53K	-53K	-53K	-53K	-53K	-53K	-53K	-53K	-57K	-305K	-422K	-438K	-472K	-492K	-424K	-771K	-787K
Preferred Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	880K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Common Stock	7.4M	7.3M	7.1M	7M	6.9M	6.9M	6.9M	6.8M	6.8M	6.7M	6.6M	6.6M	6.6M	6.6M	6.6M	6.6M	6.6M	6.6M	6.6M	6.6M
Additional Paid-In Capital	5.6M	5.4M	5.1M	4.5M	3.8M	3.4M	3.1M	3M	2.7M	2.4M	1.8M	1.6M	1.6M	1.3M	1.1M	855K	614K	489K	155K	144K
Retained Earnings	58.9M	47.5M	28.8M	28M	34.1M	37.8M	43.6M	43.2M	39.8M	36.8M	34.4M	32.1M	31.2M	29.2M	29.2M	28.4M	25.8M	22.4M	19.9M	19.5M
Accumulated Other Comprehensive Income/Loss	-3.8M	-3.4M	-3.4M	-3.7M	-3.6M	-9.6M	-6.4M	-5.9M	-6.3M	-7.6M	-7.9M	-6.3M	-7.3M	-7.2M	-4.9M	-4.9M	-5.5M	-2M	-1.8M	113K
Total Stockholders' Equity	64.5M	54.8M	37.4M	35.7M	41.2M	38.4M	47.1M	47.1M	43.8M	38.2M	34.9M	34M	31.7M	29.5M	31.5M	30.4M	27M	26.9M	24M	25.5M
Total Equity	66.2M	56.2M	38.5M	36.2M	41.5M	38.7M	47.7M	47.5M	44.1M	38.6M	35.2M	34.2M	33.7M	31.7M	33M	31.7M	28.3M	28.7M	25.2M	26.4M
Minority Interest	1.8M	1.4M	1.1M	486K	246K	288K	603K	462K	374K	310K	323K	265K	2M	2.1M	1.5M	1.2M	1.3M	1.8M	1.2M	818K
SUMMARY
Total Liabilities & Equity	194.7M	134.8M	118.9M	118.8M	89.4M	83.9M	87.2M	84.4M	80.4M	72.4M	69.5M	62.7M	68.7M	64.1M	63.1M	56.6M	52.5M	50.6M	45.2M	50.5M
Total Investments	1.9M	0.0	1.1M	1.2M	1.3M	2.5M	3.1M	4.1M	0.0	0.0	0.0	0.0	4.1M	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Debt	50.2M	11M	12.9M	67.6M	16.1M	13.8M	10.7M	5.1M	4.5M	4.2M	5.4M	3.6M	7.2M	7.1M	10.6M	5M	6.1M	5M	4.3M	9.1M
Net Debt	35.2M	-12.3M	4.8M	63.1M	10.9M	9.4M	50K	-4.7M	-8M	-983K	2.3M	-2.7M	1.4M	864K	8.2M	3.2M	2.6M	1.2M	2.1M	8.1M
Shares Outstanding	2,865,694	2,865,694	2,865,694	2,865,694	2,865,694	2,865,694	2,865,694	2,865,694	2,865,694	2,865,694	2,865,694	2,865,694	2,865,694	2,865,694	2,865,694	2,865,694	2,865,694	2,865,694	2,865,694	2,865,694

SEC Filings

KEQU - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
10-Q 10-Q 2026 Q1 Q1	March 13, 2026	January 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 11, 2026	March 11, 2026	2026	View Filing
8-K 8-K 2026 N/A	February 25, 2026	February 25, 2026	2026	View Filing
10-Q 10-Q 2025 Q4 Q4	December 12, 2025	October 31, 2025	2025	View Filing
8-K 8-K 2025 N/A	December 10, 2025	December 10, 2025	2025	View Filing
8-K 8-K 2025 N/A	December 04, 2025	December 04, 2025	2025	View Filing
8-K 8-K 2025 N/A	November 26, 2025	November 26, 2025	2025	View Filing
10-Q 10-Q 2025 Q3 Q3	September 12, 2025	July 31, 2025	2025	View Filing
8-K 8-K 2025 N/A	September 11, 2025	September 10, 2025	2025	View Filing
8-K 8-K 2025 N/A	September 10, 2025	September 10, 2025	2025	View Filing

Showing 1 to 10 of 360 filings

Related Guides

Blog Categories

Continue your KEQU research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.